Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: An increasing problem

被引：71

作者：

Al-Jasser A.M. ^{[1
]}

机构：

[1] King Saud University Fellowship of Pathology (Microbiology), Department of Microbiology, Armed Forces Hospital

来源：

Annals of Clinical Microbiology and Antimicrobials | / 5卷 / 1期

关键词：

Chronic Myeloid Leukemia; Moxifloxacin; Colistin; Gatifloxacin; Ticarcillin;

D O I：

10.1186/1476-0711-5-23

中图分类号：

学科分类号：

摘要：

Stenotrophomonas maltophilia (S. maltophilia) has recently emerged as an important nosocomial pathogen. Treatment of invasive infections caused by this organism is difficult as the bacterium is frequently resistant to a wide range of commonly used antimicrobials. Trimethoprimsulfamethoxazole (TMP - SXT) is recommended as the agent of choice for the treatment of S. maltophilia infections. However, the development of resistance to this antibiotic represents a real challenge to laboratorians and clinicians. This letter describes the first isolation of S. maltophilia resistant to TMP - SXT from two patients treated at Riyadh Armed Forces Hospital which is a major tertiary hospital in Saudi Arabia. © 2006 Al-Jasser; licensee BioMed Central Ltd.

引用

共 17 条

[1]

Lennett E.H., Baburs A., Hausler W.J., Shadomy H.J., Manual of Clinical Microbiology

[2]

Koseoglu O., Sener B., Gulmez D., Altun B., Gur D., Stenotrophomonas maltophilia as a nosocomial pathogen, New Microbiol, 27, pp. 273-279, (2004)

[3]

Denton M., Kerr K.G., Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia, Clin Microbiol Rev, 11, pp. 57-80, (1998)

[4]

Micozzi A., Venditti M., Monaco M., Friedrich A., Taglietti F., Santilli S., Martino P., Bacteremia due to Stenotrophomonas maltophilia in patients with hematological malignancies, Clin Infect Dis, 31, pp. 705-711, (2000)

[5]

Tsiodras S., Pittet D., Carmeli Y., Eliopoulos G., Boucher H., Harbath S., Clinical implications of Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: A study of 69 patients at 2 university hospitals, Scand J Infect Dis, 32, pp. 651-656, (2000)

[6]

Smit W.J., Boquest A.L., Geddes J.E., Tosolini F.A., The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management, Pathology, 26, pp. 321-324, (1994)

[7]

Vartivarian S., Anaissie E., Bodey G., Sprigg H., Rolston K., A changing pattern of susceptibility of Xanthomonas maltophilia

[8]

Implications for therapy, Antimicrob Agents Chemother, 38, pp. 624-627, (1994)

[9]

Performance Standards for Antimicrobial Susceptibility Testing 15th Informational Supplement (M 100-S15), (2005)

[10]

Pankuch G.A., Jacobs M.R., Rittenhouse S.F., Appelbaum P.C., Susceptibilities of 123 strains of Xanthomonas moltophilia to eight Blactams (including B-lactam-B-lactamase inhibitor combinations) and ciprofloxacin tested by five methods, Antimicrob Agents Chemother, 38, pp. 2317-2322, (1994)

← 1 2 →